Clinical Trial Update: Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing safety and efficacy of celecoxib vs naproxen for 6 months in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Naproxen (Naproxen)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED